1. "2017"
Formats
  1. Journal Article (3042)
  2. Meeting Abstract (1585)
  3. Book Section (234)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2030)
  2. GSK Faculty (1125)
  3. Solid Tumor Oncology Division (1100)
  4. Sloan Kettering Institute Postdocs (1019)
  5. Surgery (887)
  6. Survivorship Research (775)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (67)
  3. Michael Berger (66)
  4. Monica Morrow (65)
  5. Jedd Wolchok (61)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4910)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (376)
  4. Nature Publishing Group (310)
  5. Oxford University Press (286)
  6. American Society of Hematology (246)

More Publishers

Results (4910)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Despite increasing size of unrelated donor (URD) registries and the global CB inventory racial disparities in access to URD and CB grafts persist: A prospective 10 year analysis of 1,112 patients
    Meeting Abstract

    Boughan, K. M.; Dahi, P.; Devlin, S. M.; Byam, C.; Yoo, Y.; Mazis, C.; Davis, E.; Nhaissi, M.; Paulson, J.; Wells, D. S.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Genotype, phenotype and T cell counts at one year predict survival and long term immune reconstitution after transplantation in severe combined immune deficiency (SCID) - The Primary Immune Deficiency Treatment Consortium (PIDTC)
    Meeting Abstract

    Haddad, E.; Logan, B. R.; Griffith, L. M.; Buckley, R. H.; Parrott, R. E.; Dvorak, C. C.; Puck, J.; Prockop, S. E.; Kapoor, N.; Abdel-Azim, H.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Development of and compliance with a vitamin D monitoring and supplementation program for hematopoietic stem cell transplant (HSCT) patients
    Meeting Abstract

    Collum, K.; Featherstone, C.; Beyer, K.; Farooki, A.; Hylton, H. M.; Irby, S.; Kelly, S.; Kenny, S.; Morcerf, B.; Patterson, E.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparison of single unmanipulated umbilical cord blood or co-infusion of an umbilical cord blood graft with CD34+ cells from a third party donor in adults with acute leukemia
    Meeting Abstract

    Sanz, J.; Kwon, M.; Bautista, G.; Sanz, M. A.; Balsalobre, P.; Piñana, J. L.; Solano, C.; Duarte, R. F.; Ferrá, C.; Martín, C.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Comparable survival with organ toxicity predicting for overall survival (OS) and non-relapse mortality (NRM) in older adult patients after CD34+ selected allogeneic hematopoietic stem cell transplantation (Allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Adrianzen Herrera, D. A.; Cho, C.; Maloy, M.; Nieves, J.; Devlin, S. M.; Borrill, T.; Carlow, D.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Impact of higher-dose total body irradiation conditioning on outcome of an allogeneic hematopoietic cell transplant (HCT) in the Modern era
    Meeting Abstract

    Sabloff, M.; Wang, T.; Zhu, X.; Artz, A. S.; Adekola, K.; Abraham, A.; Auletta, J. J.; Battiwalla, M.; Beitinjaneh, A.; Bredeson, C. N.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • A phase 1/2 trial of carfilzomib + high dose melphalan conditioning for auto-HCT followed by carfilzomib maintenance for patients with relapsed multiple myeloma
    Meeting Abstract

    Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Innis-Shelton, R.; Saad, A.; Salzman, D.; Hamadani, M.; Tamari, R.; Williams, L.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Combining the disease risk index (DRI) and hematopoietic cell transplantation comorbidity index (HCT-CI) provides a comprehensive prognostic model for CD34-selected allogeneic HCT
    Meeting Abstract

    Cho, C.; Hilden, P.; Avecilla, S. T.; Barker, J. N.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; Maloy, M.; Meagher, R.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Maribavir for treatment of cytomegalovirus infections resistant or refractory to ganciclovir or foscarnet in hematopoietic stem cell transplant or solid organ transplant recipients: A randomized, dose-ranging, double-blind, phase 2 study
    Meeting Abstract

    Papanicolaou, G. A.; Silveira, F. P.; Langston, A. A.; Pereira, M. R.; Avery, R. K.; Wijatyk, A.; Wu, J. J.; Boeckh, M. J.; Marty, F. M.; Villano, S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Treatment of adenovirus (AdV) infection in allogeneic hematopoietic cell transplant (allo HCT) patients (pts) with brincidofovir: Final 36 week results from the ADVISE trial
    Meeting Abstract

    Prasad, V. K.; Papanicolaou, G. A.; Marón, G. M.; Vainorius, E.; Brundage, T. M.; Chittick, G.; Nichols, G.; Grimley, M. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save